TIAA CREF Investment Management LLC lowered its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 20.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,257,500 shares of the medical research company’s stock after selling 314,433 shares during the period. TIAA CREF Investment Management LLC owned approximately 0.32% of Thermo Fisher Scientific worth $219,396,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Peregrine Asset Advisers Inc. purchased a new stake in shares of Thermo Fisher Scientific in the second quarter valued at $709,000. Fiera Capital Corp lifted its holdings in shares of Thermo Fisher Scientific by 0.3% in the second quarter. Fiera Capital Corp now owns 133,548 shares of the medical research company’s stock valued at $23,300,000 after purchasing an additional 418 shares in the last quarter. Raymond James Trust N.A. increased its stake in shares of Thermo Fisher Scientific by 1.3% in the second quarter. Raymond James Trust N.A. now owns 10,884 shares of the medical research company’s stock worth $1,899,000 after acquiring an additional 144 shares during the last quarter. Stephens Inc. AR increased its stake in shares of Thermo Fisher Scientific by 9.2% in the second quarter. Stephens Inc. AR now owns 10,632 shares of the medical research company’s stock worth $1,855,000 after acquiring an additional 899 shares during the last quarter. Finally, Symphony Asset Management LLC increased its stake in shares of Thermo Fisher Scientific by 31.9% in the second quarter. Symphony Asset Management LLC now owns 19,700 shares of the medical research company’s stock worth $3,437,000 after acquiring an additional 4,759 shares during the last quarter. Institutional investors own 83.32% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/10/19/thermo-fisher-scientific-inc-tmo-shares-sold-by-tiaa-cref-investment-management-llc.html.

Thermo Fisher Scientific Inc (NYSE:TMO) opened at 189.22 on Thursday. The firm’s 50-day moving average is $190.20 and its 200 day moving average is $176.17. The firm has a market capitalization of $73.82 billion, a P/E ratio of 32.97 and a beta of 1.05. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The firm had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same period in the previous year, the firm posted $2.03 EPS. The company’s revenue for the quarter was up 10.2% on a year-over-year basis. Equities analysts anticipate that Thermo Fisher Scientific Inc will post $9.35 EPS for the current year.

A number of equities analysts have recently weighed in on the stock. Leerink Swann upped their price target on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a research note on Monday, October 9th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $195.00 price target on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Goldman Sachs Group, Inc. (The) assumed coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price target on the stock. Barclays PLC reaffirmed an “overweight” rating and issued a $215.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Monday, September 25th. Finally, Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 price target on the stock in a research note on Thursday, September 21st. One analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $203.64.

In other news, Director C Martin Harris sold 360 shares of the business’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total transaction of $65,149.20. Following the transaction, the director now directly owns 5,312 shares in the company, valued at approximately $961,312.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jim P. Manzi sold 11,318 shares of the business’s stock in a transaction dated Friday, August 18th. The stock was sold at an average price of $172.94, for a total transaction of $1,957,334.92. Following the transaction, the director now owns 38,757 shares in the company, valued at $6,702,635.58. The disclosure for this sale can be found here. Insiders have sold a total of 52,738 shares of company stock worth $9,302,112 over the last three months. Insiders own 0.49% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.